TDX/TDXFLX & TDXFLX THEOPHYLLINE MONOCLONAL II— 510(k) K932127

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K932127 for TDX/TDXFLX & TDXFLX THEOPHYLLINE MONOCLONAL II, Substantially Equivalent on 1993-08-09. Applicant: Abbott Laboratories.

Clearance details

Applicant: Abbott Laboratories
Product code: Code LGS
Advisory panel: Clinical Toxicology
Date received: 1993-05-03
Decision date: 1993-08-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.